nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Etoposide—sarcoma	0.413	1	CbGbCtD
Raltegravir—CCR1—myometrium—sarcoma	0.0203	0.137	CbGeAlD
Raltegravir—CCR1—seminal vesicle—sarcoma	0.0184	0.124	CbGeAlD
Raltegravir—CCR1—hematopoietic system—sarcoma	0.0175	0.118	CbGeAlD
Raltegravir—CCR1—connective tissue—sarcoma	0.0168	0.114	CbGeAlD
Raltegravir—CCR1—uterus—sarcoma	0.0132	0.0891	CbGeAlD
Raltegravir—CCR1—lymphoid tissue—sarcoma	0.0123	0.083	CbGeAlD
Raltegravir—CCR1—tendon—sarcoma	0.0115	0.078	CbGeAlD
Raltegravir—CCR1—bone marrow—sarcoma	0.0112	0.0756	CbGeAlD
Raltegravir—CCR1—liver—sarcoma	0.00904	0.0611	CbGeAlD
Raltegravir—UGT1A1—hematopoietic system—sarcoma	0.00717	0.0485	CbGeAlD
Raltegravir—CCR1—lymph node—sarcoma	0.00693	0.0468	CbGeAlD
Raltegravir—UGT1A1—liver—sarcoma	0.00372	0.0251	CbGeAlD
Raltegravir—Hypersensitivity—Dactinomycin—sarcoma	0.00055	0.00125	CcSEcCtD
Raltegravir—Gastrointestinal pain—Vincristine—sarcoma	0.000546	0.00124	CcSEcCtD
Raltegravir—Gastritis—Epirubicin—sarcoma	0.000546	0.00124	CcSEcCtD
Raltegravir—Confusional state—Etoposide—sarcoma	0.000545	0.00124	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000544	0.00124	CcSEcCtD
Raltegravir—Mood swings—Doxorubicin—sarcoma	0.00054	0.00123	CcSEcCtD
Raltegravir—Asthenia—Thiotepa—sarcoma	0.00054	0.00123	CcSEcCtD
Raltegravir—Infection—Etoposide—sarcoma	0.000537	0.00122	CcSEcCtD
Raltegravir—Abdominal distension—Epirubicin—sarcoma	0.000536	0.00122	CcSEcCtD
Raltegravir—Asthenia—Dactinomycin—sarcoma	0.000536	0.00122	CcSEcCtD
Raltegravir—Feeling abnormal—Mitoxantrone—sarcoma	0.000535	0.00122	CcSEcCtD
Raltegravir—Blood creatinine increased—Doxorubicin—sarcoma	0.000534	0.00122	CcSEcCtD
Raltegravir—Influenza—Epirubicin—sarcoma	0.000533	0.00121	CcSEcCtD
Raltegravir—Pruritus—Thiotepa—sarcoma	0.000532	0.00121	CcSEcCtD
Raltegravir—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000531	0.00121	CcSEcCtD
Raltegravir—Thrombocytopenia—Etoposide—sarcoma	0.000529	0.00121	CcSEcCtD
Raltegravir—Eosinophilia—Epirubicin—sarcoma	0.000528	0.0012	CcSEcCtD
Raltegravir—Abdominal pain—Vincristine—sarcoma	0.000527	0.0012	CcSEcCtD
Raltegravir—Body temperature increased—Vincristine—sarcoma	0.000527	0.0012	CcSEcCtD
Raltegravir—Skin disorder—Etoposide—sarcoma	0.000525	0.0012	CcSEcCtD
Raltegravir—Dry skin—Doxorubicin—sarcoma	0.000523	0.00119	CcSEcCtD
Raltegravir—Hyperhidrosis—Etoposide—sarcoma	0.000523	0.00119	CcSEcCtD
Raltegravir—Abdominal pain upper—Doxorubicin—sarcoma	0.000521	0.00119	CcSEcCtD
Raltegravir—Urticaria—Mitoxantrone—sarcoma	0.000516	0.00118	CcSEcCtD
Raltegravir—Breast disorder—Doxorubicin—sarcoma	0.000515	0.00117	CcSEcCtD
Raltegravir—Diarrhoea—Thiotepa—sarcoma	0.000515	0.00117	CcSEcCtD
Raltegravir—Abdominal pain—Mitoxantrone—sarcoma	0.000514	0.00117	CcSEcCtD
Raltegravir—Body temperature increased—Mitoxantrone—sarcoma	0.000514	0.00117	CcSEcCtD
Raltegravir—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000514	0.00117	CcSEcCtD
Raltegravir—Bronchitis—Epirubicin—sarcoma	0.000512	0.00117	CcSEcCtD
Raltegravir—Diarrhoea—Dactinomycin—sarcoma	0.000511	0.00116	CcSEcCtD
Raltegravir—Nasopharyngitis—Doxorubicin—sarcoma	0.00051	0.00116	CcSEcCtD
Raltegravir—Gastritis—Doxorubicin—sarcoma	0.000505	0.00115	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000503	0.00115	CcSEcCtD
Raltegravir—Neutropenia—Epirubicin—sarcoma	0.000498	0.00114	CcSEcCtD
Raltegravir—Dizziness—Thiotepa—sarcoma	0.000498	0.00113	CcSEcCtD
Raltegravir—Abdominal distension—Doxorubicin—sarcoma	0.000496	0.00113	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Epirubicin—sarcoma	0.000495	0.00113	CcSEcCtD
Raltegravir—Influenza—Doxorubicin—sarcoma	0.000493	0.00112	CcSEcCtD
Raltegravir—Hypersensitivity—Vincristine—sarcoma	0.000492	0.00112	CcSEcCtD
Raltegravir—Eosinophilia—Doxorubicin—sarcoma	0.000488	0.00111	CcSEcCtD
Raltegravir—Paraesthesia—Etoposide—sarcoma	0.000485	0.00111	CcSEcCtD
Raltegravir—Weight increased—Epirubicin—sarcoma	0.000485	0.0011	CcSEcCtD
Raltegravir—Weight decreased—Epirubicin—sarcoma	0.000482	0.0011	CcSEcCtD
Raltegravir—Hyperglycaemia—Epirubicin—sarcoma	0.000481	0.00109	CcSEcCtD
Raltegravir—Somnolence—Etoposide—sarcoma	0.000481	0.00109	CcSEcCtD
Raltegravir—Hypersensitivity—Mitoxantrone—sarcoma	0.000479	0.00109	CcSEcCtD
Raltegravir—Asthenia—Vincristine—sarcoma	0.000479	0.00109	CcSEcCtD
Raltegravir—Vomiting—Thiotepa—sarcoma	0.000478	0.00109	CcSEcCtD
Raltegravir—Infestation NOS—Epirubicin—sarcoma	0.000475	0.00108	CcSEcCtD
Raltegravir—Infestation—Epirubicin—sarcoma	0.000475	0.00108	CcSEcCtD
Raltegravir—Vomiting—Dactinomycin—sarcoma	0.000475	0.00108	CcSEcCtD
Raltegravir—Rash—Thiotepa—sarcoma	0.000474	0.00108	CcSEcCtD
Raltegravir—Bronchitis—Doxorubicin—sarcoma	0.000474	0.00108	CcSEcCtD
Raltegravir—Dermatitis—Thiotepa—sarcoma	0.000474	0.00108	CcSEcCtD
Raltegravir—Headache—Thiotepa—sarcoma	0.000471	0.00107	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000471	0.00107	CcSEcCtD
Raltegravir—Rash—Dactinomycin—sarcoma	0.000471	0.00107	CcSEcCtD
Raltegravir—Decreased appetite—Etoposide—sarcoma	0.00047	0.00107	CcSEcCtD
Raltegravir—Renal failure—Epirubicin—sarcoma	0.000467	0.00106	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Etoposide—sarcoma	0.000467	0.00106	CcSEcCtD
Raltegravir—Asthenia—Mitoxantrone—sarcoma	0.000466	0.00106	CcSEcCtD
Raltegravir—Fatigue—Etoposide—sarcoma	0.000466	0.00106	CcSEcCtD
Raltegravir—Neuropathy peripheral—Epirubicin—sarcoma	0.000466	0.00106	CcSEcCtD
Raltegravir—Pain—Etoposide—sarcoma	0.000462	0.00105	CcSEcCtD
Raltegravir—Constipation—Etoposide—sarcoma	0.000462	0.00105	CcSEcCtD
Raltegravir—Neutropenia—Doxorubicin—sarcoma	0.000461	0.00105	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000458	0.00104	CcSEcCtD
Raltegravir—Diarrhoea—Vincristine—sarcoma	0.000457	0.00104	CcSEcCtD
Raltegravir—Haematuria—Epirubicin—sarcoma	0.000453	0.00103	CcSEcCtD
Raltegravir—Hepatobiliary disease—Epirubicin—sarcoma	0.000449	0.00102	CcSEcCtD
Raltegravir—Weight increased—Doxorubicin—sarcoma	0.000449	0.00102	CcSEcCtD
Raltegravir—Epistaxis—Epirubicin—sarcoma	0.000448	0.00102	CcSEcCtD
Raltegravir—Nausea—Thiotepa—sarcoma	0.000447	0.00102	CcSEcCtD
Raltegravir—Weight decreased—Doxorubicin—sarcoma	0.000446	0.00102	CcSEcCtD
Raltegravir—Feeling abnormal—Etoposide—sarcoma	0.000445	0.00101	CcSEcCtD
Raltegravir—Hyperglycaemia—Doxorubicin—sarcoma	0.000445	0.00101	CcSEcCtD
Raltegravir—Diarrhoea—Mitoxantrone—sarcoma	0.000445	0.00101	CcSEcCtD
Raltegravir—Nausea—Dactinomycin—sarcoma	0.000444	0.00101	CcSEcCtD
Raltegravir—Gastrointestinal pain—Etoposide—sarcoma	0.000442	0.00101	CcSEcCtD
Raltegravir—Dizziness—Vincristine—sarcoma	0.000441	0.00101	CcSEcCtD
Raltegravir—Infestation NOS—Doxorubicin—sarcoma	0.00044	0.001	CcSEcCtD
Raltegravir—Infestation—Doxorubicin—sarcoma	0.00044	0.001	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000436	0.000993	CcSEcCtD
Raltegravir—Renal failure—Doxorubicin—sarcoma	0.000432	0.000984	CcSEcCtD
Raltegravir—Neuropathy peripheral—Doxorubicin—sarcoma	0.000431	0.000982	CcSEcCtD
Raltegravir—Urticaria—Etoposide—sarcoma	0.000429	0.000978	CcSEcCtD
Raltegravir—Body temperature increased—Etoposide—sarcoma	0.000427	0.000973	CcSEcCtD
Raltegravir—Abdominal pain—Etoposide—sarcoma	0.000427	0.000973	CcSEcCtD
Raltegravir—Hepatitis—Epirubicin—sarcoma	0.000426	0.000972	CcSEcCtD
Raltegravir—Hypoaesthesia—Epirubicin—sarcoma	0.000424	0.000967	CcSEcCtD
Raltegravir—Vomiting—Vincristine—sarcoma	0.000424	0.000966	CcSEcCtD
Raltegravir—Urinary tract disorder—Epirubicin—sarcoma	0.000421	0.000959	CcSEcCtD
Raltegravir—Rash—Vincristine—sarcoma	0.000421	0.000958	CcSEcCtD
Raltegravir—Dermatitis—Vincristine—sarcoma	0.00042	0.000958	CcSEcCtD
Raltegravir—Oedema peripheral—Epirubicin—sarcoma	0.00042	0.000957	CcSEcCtD
Raltegravir—Haematuria—Doxorubicin—sarcoma	0.000419	0.000955	CcSEcCtD
Raltegravir—Connective tissue disorder—Epirubicin—sarcoma	0.000419	0.000955	CcSEcCtD
Raltegravir—Urethral disorder—Epirubicin—sarcoma	0.000418	0.000952	CcSEcCtD
Raltegravir—Headache—Vincristine—sarcoma	0.000418	0.000952	CcSEcCtD
Raltegravir—Hepatobiliary disease—Doxorubicin—sarcoma	0.000416	0.000947	CcSEcCtD
Raltegravir—Epistaxis—Doxorubicin—sarcoma	0.000415	0.000945	CcSEcCtD
Raltegravir—Vomiting—Mitoxantrone—sarcoma	0.000413	0.000941	CcSEcCtD
Raltegravir—Visual impairment—Epirubicin—sarcoma	0.000411	0.000936	CcSEcCtD
Raltegravir—Rash—Mitoxantrone—sarcoma	0.00041	0.000933	CcSEcCtD
Raltegravir—Dermatitis—Mitoxantrone—sarcoma	0.000409	0.000933	CcSEcCtD
Raltegravir—Headache—Mitoxantrone—sarcoma	0.000407	0.000927	CcSEcCtD
Raltegravir—Erythema multiforme—Epirubicin—sarcoma	0.000403	0.000919	CcSEcCtD
Raltegravir—Eye disorder—Epirubicin—sarcoma	0.000399	0.000908	CcSEcCtD
Raltegravir—Hypersensitivity—Etoposide—sarcoma	0.000398	0.000907	CcSEcCtD
Raltegravir—Tinnitus—Epirubicin—sarcoma	0.000398	0.000906	CcSEcCtD
Raltegravir—Nausea—Vincristine—sarcoma	0.000396	0.000903	CcSEcCtD
Raltegravir—Cardiac disorder—Epirubicin—sarcoma	0.000396	0.000902	CcSEcCtD
Raltegravir—Hepatitis—Doxorubicin—sarcoma	0.000395	0.000899	CcSEcCtD
Raltegravir—Hypoaesthesia—Doxorubicin—sarcoma	0.000393	0.000894	CcSEcCtD
Raltegravir—Urinary tract disorder—Doxorubicin—sarcoma	0.00039	0.000888	CcSEcCtD
Raltegravir—Oedema peripheral—Doxorubicin—sarcoma	0.000389	0.000886	CcSEcCtD
Raltegravir—Asthenia—Etoposide—sarcoma	0.000388	0.000883	CcSEcCtD
Raltegravir—Connective tissue disorder—Doxorubicin—sarcoma	0.000388	0.000883	CcSEcCtD
Raltegravir—Angiopathy—Epirubicin—sarcoma	0.000387	0.000881	CcSEcCtD
Raltegravir—Urethral disorder—Doxorubicin—sarcoma	0.000387	0.000881	CcSEcCtD
Raltegravir—Nausea—Mitoxantrone—sarcoma	0.000386	0.000879	CcSEcCtD
Raltegravir—Immune system disorder—Epirubicin—sarcoma	0.000385	0.000878	CcSEcCtD
Raltegravir—Mediastinal disorder—Epirubicin—sarcoma	0.000384	0.000876	CcSEcCtD
Raltegravir—Chills—Epirubicin—sarcoma	0.000383	0.000872	CcSEcCtD
Raltegravir—Pruritus—Etoposide—sarcoma	0.000382	0.000871	CcSEcCtD
Raltegravir—Visual impairment—Doxorubicin—sarcoma	0.00038	0.000866	CcSEcCtD
Raltegravir—Alopecia—Epirubicin—sarcoma	0.000377	0.000859	CcSEcCtD
Raltegravir—Mental disorder—Epirubicin—sarcoma	0.000374	0.000851	CcSEcCtD
Raltegravir—Erythema multiforme—Doxorubicin—sarcoma	0.000373	0.00085	CcSEcCtD
Raltegravir—Malnutrition—Epirubicin—sarcoma	0.000371	0.000846	CcSEcCtD
Raltegravir—Erythema—Epirubicin—sarcoma	0.000371	0.000846	CcSEcCtD
Raltegravir—Diarrhoea—Etoposide—sarcoma	0.00037	0.000843	CcSEcCtD
Raltegravir—Eye disorder—Doxorubicin—sarcoma	0.000369	0.00084	CcSEcCtD
Raltegravir—Tinnitus—Doxorubicin—sarcoma	0.000368	0.000838	CcSEcCtD
Raltegravir—Cardiac disorder—Doxorubicin—sarcoma	0.000366	0.000834	CcSEcCtD
Raltegravir—Flatulence—Epirubicin—sarcoma	0.000366	0.000833	CcSEcCtD
Raltegravir—Dysgeusia—Epirubicin—sarcoma	0.000364	0.000828	CcSEcCtD
Raltegravir—Nervousness—Epirubicin—sarcoma	0.000361	0.000821	CcSEcCtD
Raltegravir—Back pain—Epirubicin—sarcoma	0.000359	0.000818	CcSEcCtD
Raltegravir—Angiopathy—Doxorubicin—sarcoma	0.000358	0.000816	CcSEcCtD
Raltegravir—Dizziness—Etoposide—sarcoma	0.000357	0.000814	CcSEcCtD
Raltegravir—Immune system disorder—Doxorubicin—sarcoma	0.000356	0.000812	CcSEcCtD
Raltegravir—Mediastinal disorder—Doxorubicin—sarcoma	0.000356	0.00081	CcSEcCtD
Raltegravir—Chills—Doxorubicin—sarcoma	0.000354	0.000807	CcSEcCtD
Raltegravir—Alopecia—Doxorubicin—sarcoma	0.000349	0.000794	CcSEcCtD
Raltegravir—Mental disorder—Doxorubicin—sarcoma	0.000346	0.000788	CcSEcCtD
Raltegravir—Ill-defined disorder—Epirubicin—sarcoma	0.000344	0.000785	CcSEcCtD
Raltegravir—Vomiting—Etoposide—sarcoma	0.000344	0.000783	CcSEcCtD
Raltegravir—Malnutrition—Doxorubicin—sarcoma	0.000344	0.000783	CcSEcCtD
Raltegravir—Erythema—Doxorubicin—sarcoma	0.000344	0.000783	CcSEcCtD
Raltegravir—Anaemia—Epirubicin—sarcoma	0.000343	0.000782	CcSEcCtD
Raltegravir—Agitation—Epirubicin—sarcoma	0.000341	0.000777	CcSEcCtD
Raltegravir—Rash—Etoposide—sarcoma	0.000341	0.000776	CcSEcCtD
Raltegravir—Dermatitis—Etoposide—sarcoma	0.00034	0.000776	CcSEcCtD
Raltegravir—Headache—Etoposide—sarcoma	0.000339	0.000771	CcSEcCtD
Raltegravir—Flatulence—Doxorubicin—sarcoma	0.000338	0.000771	CcSEcCtD
Raltegravir—Dysgeusia—Doxorubicin—sarcoma	0.000336	0.000766	CcSEcCtD
Raltegravir—Malaise—Epirubicin—sarcoma	0.000335	0.000763	CcSEcCtD
Raltegravir—Nervousness—Doxorubicin—sarcoma	0.000334	0.00076	CcSEcCtD
Raltegravir—Vertigo—Epirubicin—sarcoma	0.000334	0.00076	CcSEcCtD
Raltegravir—Back pain—Doxorubicin—sarcoma	0.000332	0.000757	CcSEcCtD
Raltegravir—Palpitations—Epirubicin—sarcoma	0.000328	0.000747	CcSEcCtD
Raltegravir—Cough—Epirubicin—sarcoma	0.000324	0.000738	CcSEcCtD
Raltegravir—Nausea—Etoposide—sarcoma	0.000321	0.000731	CcSEcCtD
Raltegravir—Hypertension—Epirubicin—sarcoma	0.000321	0.00073	CcSEcCtD
Raltegravir—Ill-defined disorder—Doxorubicin—sarcoma	0.000319	0.000726	CcSEcCtD
Raltegravir—Anaemia—Doxorubicin—sarcoma	0.000317	0.000723	CcSEcCtD
Raltegravir—Myalgia—Epirubicin—sarcoma	0.000316	0.00072	CcSEcCtD
Raltegravir—Arthralgia—Epirubicin—sarcoma	0.000316	0.00072	CcSEcCtD
Raltegravir—Chest pain—Epirubicin—sarcoma	0.000316	0.00072	CcSEcCtD
Raltegravir—Agitation—Doxorubicin—sarcoma	0.000316	0.000719	CcSEcCtD
Raltegravir—Anxiety—Epirubicin—sarcoma	0.000315	0.000718	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000314	0.000715	CcSEcCtD
Raltegravir—Discomfort—Epirubicin—sarcoma	0.000312	0.000711	CcSEcCtD
Raltegravir—Malaise—Doxorubicin—sarcoma	0.00031	0.000706	CcSEcCtD
Raltegravir—Dry mouth—Epirubicin—sarcoma	0.000309	0.000704	CcSEcCtD
Raltegravir—Vertigo—Doxorubicin—sarcoma	0.000309	0.000703	CcSEcCtD
Raltegravir—Confusional state—Epirubicin—sarcoma	0.000306	0.000696	CcSEcCtD
Raltegravir—Palpitations—Doxorubicin—sarcoma	0.000304	0.000692	CcSEcCtD
Raltegravir—Infection—Epirubicin—sarcoma	0.000301	0.000686	CcSEcCtD
Raltegravir—Cough—Doxorubicin—sarcoma	0.0003	0.000683	CcSEcCtD
Raltegravir—Nervous system disorder—Epirubicin—sarcoma	0.000297	0.000677	CcSEcCtD
Raltegravir—Thrombocytopenia—Epirubicin—sarcoma	0.000297	0.000676	CcSEcCtD
Raltegravir—Hypertension—Doxorubicin—sarcoma	0.000297	0.000676	CcSEcCtD
Raltegravir—Skin disorder—Epirubicin—sarcoma	0.000294	0.00067	CcSEcCtD
Raltegravir—Hyperhidrosis—Epirubicin—sarcoma	0.000293	0.000667	CcSEcCtD
Raltegravir—Myalgia—Doxorubicin—sarcoma	0.000292	0.000666	CcSEcCtD
Raltegravir—Chest pain—Doxorubicin—sarcoma	0.000292	0.000666	CcSEcCtD
Raltegravir—Arthralgia—Doxorubicin—sarcoma	0.000292	0.000666	CcSEcCtD
Raltegravir—Anxiety—Doxorubicin—sarcoma	0.000291	0.000664	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00029	0.000662	CcSEcCtD
Raltegravir—Discomfort—Doxorubicin—sarcoma	0.000289	0.000658	CcSEcCtD
Raltegravir—Dry mouth—Doxorubicin—sarcoma	0.000286	0.000652	CcSEcCtD
Raltegravir—Confusional state—Doxorubicin—sarcoma	0.000283	0.000644	CcSEcCtD
Raltegravir—Infection—Doxorubicin—sarcoma	0.000279	0.000634	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000276	0.000629	CcSEcCtD
Raltegravir—Nervous system disorder—Doxorubicin—sarcoma	0.000275	0.000626	CcSEcCtD
Raltegravir—Thrombocytopenia—Doxorubicin—sarcoma	0.000274	0.000625	CcSEcCtD
Raltegravir—Insomnia—Epirubicin—sarcoma	0.000274	0.000624	CcSEcCtD
Raltegravir—Skin disorder—Doxorubicin—sarcoma	0.000272	0.00062	CcSEcCtD
Raltegravir—Paraesthesia—Epirubicin—sarcoma	0.000272	0.00062	CcSEcCtD
Raltegravir—Hyperhidrosis—Doxorubicin—sarcoma	0.000271	0.000617	CcSEcCtD
Raltegravir—Somnolence—Epirubicin—sarcoma	0.000269	0.000614	CcSEcCtD
Raltegravir—Dyspepsia—Epirubicin—sarcoma	0.000267	0.000608	CcSEcCtD
Raltegravir—Decreased appetite—Epirubicin—sarcoma	0.000263	0.0006	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Epirubicin—sarcoma	0.000262	0.000596	CcSEcCtD
Raltegravir—Fatigue—Epirubicin—sarcoma	0.000261	0.000595	CcSEcCtD
Raltegravir—Pain—Epirubicin—sarcoma	0.000259	0.00059	CcSEcCtD
Raltegravir—Constipation—Epirubicin—sarcoma	0.000259	0.00059	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000255	0.000582	CcSEcCtD
Raltegravir—Insomnia—Doxorubicin—sarcoma	0.000254	0.000578	CcSEcCtD
Raltegravir—Paraesthesia—Doxorubicin—sarcoma	0.000252	0.000573	CcSEcCtD
Raltegravir—Feeling abnormal—Epirubicin—sarcoma	0.00025	0.000569	CcSEcCtD
Raltegravir—Somnolence—Doxorubicin—sarcoma	0.000249	0.000568	CcSEcCtD
Raltegravir—Gastrointestinal pain—Epirubicin—sarcoma	0.000248	0.000564	CcSEcCtD
Raltegravir—Dyspepsia—Doxorubicin—sarcoma	0.000247	0.000562	CcSEcCtD
Raltegravir—Decreased appetite—Doxorubicin—sarcoma	0.000244	0.000555	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000242	0.000551	CcSEcCtD
Raltegravir—Fatigue—Doxorubicin—sarcoma	0.000242	0.000551	CcSEcCtD
Raltegravir—Urticaria—Epirubicin—sarcoma	0.000241	0.000548	CcSEcCtD
Raltegravir—Pain—Doxorubicin—sarcoma	0.00024	0.000546	CcSEcCtD
Raltegravir—Constipation—Doxorubicin—sarcoma	0.00024	0.000546	CcSEcCtD
Raltegravir—Body temperature increased—Epirubicin—sarcoma	0.00024	0.000546	CcSEcCtD
Raltegravir—Abdominal pain—Epirubicin—sarcoma	0.00024	0.000546	CcSEcCtD
Raltegravir—Feeling abnormal—Doxorubicin—sarcoma	0.000231	0.000526	CcSEcCtD
Raltegravir—Gastrointestinal pain—Doxorubicin—sarcoma	0.000229	0.000522	CcSEcCtD
Raltegravir—Hypersensitivity—Epirubicin—sarcoma	0.000223	0.000509	CcSEcCtD
Raltegravir—Urticaria—Doxorubicin—sarcoma	0.000223	0.000507	CcSEcCtD
Raltegravir—Body temperature increased—Doxorubicin—sarcoma	0.000222	0.000505	CcSEcCtD
Raltegravir—Abdominal pain—Doxorubicin—sarcoma	0.000222	0.000505	CcSEcCtD
Raltegravir—Asthenia—Epirubicin—sarcoma	0.000217	0.000495	CcSEcCtD
Raltegravir—Pruritus—Epirubicin—sarcoma	0.000214	0.000488	CcSEcCtD
Raltegravir—Diarrhoea—Epirubicin—sarcoma	0.000207	0.000472	CcSEcCtD
Raltegravir—Hypersensitivity—Doxorubicin—sarcoma	0.000207	0.000471	CcSEcCtD
Raltegravir—Asthenia—Doxorubicin—sarcoma	0.000201	0.000458	CcSEcCtD
Raltegravir—Dizziness—Epirubicin—sarcoma	0.0002	0.000456	CcSEcCtD
Raltegravir—Pruritus—Doxorubicin—sarcoma	0.000198	0.000452	CcSEcCtD
Raltegravir—Vomiting—Epirubicin—sarcoma	0.000193	0.000439	CcSEcCtD
Raltegravir—Diarrhoea—Doxorubicin—sarcoma	0.000192	0.000437	CcSEcCtD
Raltegravir—Rash—Epirubicin—sarcoma	0.000191	0.000435	CcSEcCtD
Raltegravir—Dermatitis—Epirubicin—sarcoma	0.000191	0.000435	CcSEcCtD
Raltegravir—Headache—Epirubicin—sarcoma	0.00019	0.000432	CcSEcCtD
Raltegravir—Dizziness—Doxorubicin—sarcoma	0.000185	0.000422	CcSEcCtD
Raltegravir—Nausea—Epirubicin—sarcoma	0.00018	0.00041	CcSEcCtD
Raltegravir—Vomiting—Doxorubicin—sarcoma	0.000178	0.000406	CcSEcCtD
Raltegravir—Rash—Doxorubicin—sarcoma	0.000177	0.000403	CcSEcCtD
Raltegravir—Dermatitis—Doxorubicin—sarcoma	0.000177	0.000402	CcSEcCtD
Raltegravir—Headache—Doxorubicin—sarcoma	0.000176	0.0004	CcSEcCtD
Raltegravir—Nausea—Doxorubicin—sarcoma	0.000167	0.000379	CcSEcCtD
